drugset / Trial / NCT01156948

Misoprostol For Nulliparous Women Before Hysteroscopy

NCT01156948

Phase 3 Unknown 120 enrolled Wenzhou Medical University
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the impact of 400-microgram self-administered vaginal versus self-administered oral misoprostol at home on preoperative cervical ripening in nulliparous women prior to outpatient hysteroscopy.

Timeline

Start
2008-05
Primary completion
2010-08
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Other

Indications